These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34086495)

  • 1. Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy.
    Rodbard D
    Diabetes Technol Ther; 2021 Oct; 23(10):692-704. PubMed ID: 34086495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose Time In Range, Time Above Range, and Time Below Range Depend on Mean or Median Glucose or HbA1c, Glucose Coefficient of Variation, and Shape of the Glucose Distribution.
    Rodbard D
    Diabetes Technol Ther; 2020 Jul; 22(7):492-500. PubMed ID: 31886733
    [No Abstract]   [Full Text] [Related]  

  • 3. Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes.
    Montaser E; Fabris C; Kovatchev B
    Diabetes Technol Ther; 2022 Nov; 24(11):797-804. PubMed ID: 35714355
    [No Abstract]   [Full Text] [Related]  

  • 4. The Comprehensive Glucose Pentagon: A Glucose-Centric Composite Metric for Assessing Glycemic Control in Persons With Diabetes.
    Vigersky RA; Shin J; Jiang B; Siegmund T; McMahon C; Thomas A
    J Diabetes Sci Technol; 2018 Jan; 12(1):114-123. PubMed ID: 28748705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
    Rodbard D
    Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
    Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
    Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic Metrics Derived From Intermittently Scanned Continuous Glucose Monitoring.
    Hansen KW; Bibby BM
    J Diabetes Sci Technol; 2022 Jan; 16(1):113-119. PubMed ID: 33269634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control.
    Yoo JH; Kim JH
    Diabetes Metab J; 2020 Dec; 44(6):828-839. PubMed ID: 33389957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia.
    Gómez AM; Henao DC; Imitola Madero A; Taboada LB; Cruz V; Robledo Gómez MA; Rondón M; Muñoz-Velandia O; García-Jaramillo M; León Vargas FM
    Diabetes Technol Ther; 2019 Aug; 21(8):430-439. PubMed ID: 31219350
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
    Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Glycemic Variability Is Associated with Worse Continuous Glucose Monitoring Metrics in Children and Adolescents with Type 1 Diabetes.
    Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Horm Res Paediatr; 2021; 94(9-10):369-373. PubMed ID: 34915493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
    Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D
    Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality.
    Kim JY; Yoo JH; Kim JH
    Diabetes Technol Ther; 2023 Dec; 25(12):883-892. PubMed ID: 37668665
    [No Abstract]   [Full Text] [Related]  

  • 15. Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with "Risk Indices".
    Rodbard D
    Diabetes Technol Ther; 2018 May; 20(5):325-334. PubMed ID: 29792750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
    Beck RW; Bergenstal RM; Cheng P; Kollman C; Carlson AL; Johnson ML; Rodbard D
    J Diabetes Sci Technol; 2019 Jul; 13(4):614-626. PubMed ID: 30636519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
    Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
    Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
    Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
    Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factor Analysis for Type 2 Diabetes Patients About Hypoglycemia Using Continuous Glucose Monitoring: Results from a Prospective Observational Study.
    Uemura F; Okada Y; Mita T; Torimoto K; Wakasugi S; Katakami N; Yoshii H; Matsushita K; Nishida K; Inokuchi N; Tanaka Y; Gosho M; Shimomura I; Watada H
    Diabetes Technol Ther; 2022 Jun; 24(6):435-445. PubMed ID: 35049378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.